According to pharmacokinetic data published in PubMed Central (PMC9272494), it has an average half-life of about 7 days, resulting in slow, steady elimination over time
Patients are encouraged to disclose all of their medications and medical history to their healthcare providers to avoid drug interactions and report any side effects
Are there any safety concerns specific to using FSA funds for compounded medications
Additionally, the FDA approved oral semaglutide (Wegovy pill, 25 mg) for obesity in December 2025, marking the first GLP-1 pill for weight loss ( [19] )
This allows the full dose to disperse into the tissue before you withdraw
Although nausea was commonly classified as moderate due to its associated loss of appetite and significant weight loss, this was rather an expected effect than a true AE and also a reason why patients with IIH have been offered to be treated with GLP-1-RAs in the first place